## Abstract The relative merits of antibody response and virus shedding as markers of cytomegalovirus (CMV) infection among cyclosporinโtreated renal allograft recipients were analysed. CMVโspecific antibody was assayed by lgGโspecific radioimmunosorbent test (RIST) and by complement fixation test
Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients
โ Scribed by Tony Wong; Sylvie Lavaud; Olivier Toupance; Jocelyne Carquin; Alain Wynckel; Jean-Pierre Melin; Catherine Hanrotel; Jacques Chanard
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 667 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
High dose oral acyclovir has been reported to be effective in preventing both cytomegalovirus (CMV) infection and disease in renal transplant recipients. We conducted a case-controlled study in which 42 cadaveric kidney transplant recipients were prophylactically treated with high dose oral acyclovi
## Abstract Serum complement profiles of 19 renal transplant recipients were studied serially before and after renal transplantation to determine if there is any relationship between cytomegalovirus (CMV) infection and alteration in the serum complement (C) levels. Most patients had low serum C3 an
## Abstract In a study of the effects on renal allograft survival of HLA mismatching, mismatching for cytomegalovirus (CMV) antibody status, and postโtransplant CMV infection, 148 cyclosporinโtreated renal transplant recipients were given kidneys optimally matched for HLAโA, โB, and โDR antigens bu
To detect cytomegalovirus (CMV) infections, a total of 1,074 cultures of urine, saliva, or blood were collected weekly from 43 consecutive patients undergoing allogeneic bone marrow transplantation. Twenty-three patients were seronegative before transplant and primary infection occurred in 2 (9%). T